Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2019 Jan 24;28(5):632–639. doi: 10.1002/pds.4718

Table 3.

Random sample of patients with possible incident T2DM by computable phenotype (CP) and site among selected health care systems in PCORnet, 2012-2016

Total Reviewed Total Confirmed PPV1 (95% CI2)
Overall 916 53 5.8 (4.5, 7.5)

By case type
 CP1 - Diabetes diagnosis and medication use 573 38 6.6 (4.9, 9.0)
 CP2 - Diabetes diagnosis and HbA1c ≥6.5% 332 13 3.9 (2.3, 6.6)
 CP3 - HbA1c ≥6.5% and medication use 11 2 18.2 (5.1, 47.7)

By site
 Vanderbilt University Health System 199 6 3.0 (1.4, 6.4)
 OneFlorida 213 20 9.4 (6.2, 14.1)
 University of North Carolina 307 20 6.5 (4.3, 9.8)
 Tulane 197 7 3.6 (1.7, 7.2)
1

PPV: Positive predictive value

2

Confidence interval using Wilson’s formula